OKYO Pharma Limited (NASDAQ:OKYO) Sees Significant Decrease in Short Interest

OKYO Pharma Limited (NASDAQ:OKYO) was the target of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 217,900 shares, a drop of 35.5% from the February 28th total of 338,000 shares. Currently, 0.9% of the shares of the company are short sold. Based on an average daily volume of 178,700 shares, the short-interest ratio is presently 1.2 days.

Analysts Set New Price Targets

Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of OKYO Pharma in a research report on Tuesday, February 18th.

OKYO Pharma Stock Performance

Shares of NASDAQ:OKYO traded down $0.08 on Friday, reaching $1.35. 44,082 shares of the company’s stock were exchanged, compared to its average volume of 114,402. The company has a fifty day moving average of $1.21 and a 200-day moving average of $1.12. OKYO Pharma has a twelve month low of $0.81 and a twelve month high of $1.74.

About OKYO Pharma

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease.